{"id":48074,"date":"2022-09-07T19:01:37","date_gmt":"2022-09-07T17:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/"},"modified":"2022-09-07T19:01:37","modified_gmt":"2022-09-07T17:01:37","slug":"global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/","title":{"rendered":"Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global Chronic Pain Clinical Trial Pipeline Highlights – 2022”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThis report provides the most up-to-date information on key pipeline products within the global Chronic Pain market.\n<\/p>\n

\nIt covers emerging therapies for Chronic Pain in active clinical development stages including early and late stage clinical trials.\n<\/p>\n

\nThe pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.\n<\/p>\n

\nClinical Trial Stages: <\/strong>The report provides Chronic Pain pipeline products by clinical trial stages including both early and late stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.\n<\/p>\n

\nDrug Mechanism Classes: <\/strong>The report provides Chronic Pain pipeline products by their dominant mechanism of action\/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.\n<\/p>\n

\nCompany: <\/strong>The report provides Chronic Pain pipeline products by the company.\n<\/p>\n

\nShort-term Launch Highlights: <\/strong>Find out which Chronic Pain pipeline products will be launched in the US and Ex-US till 2025.\n<\/p>\n

\nKey Topics Covered:<\/strong>\n<\/p>\n

\n1. Chronic Pain Pipeline by Stages\n<\/p>\n

\n2. Chronic Pain Phase 3 Clinical Trial Insights\n<\/p>\n

\n3. Chronic Pain Phase 2 Clinical Trial Insights\n<\/p>\n

\n4. Chronic Pain Phase 1 Clinical Trial Insights\n<\/p>\n

\n5. Chronic Pain Preclinical Research Insights\n<\/p>\n

\n6. Chronic Pain Discovery Stage Insights\n<\/p>\n

\n7. Appendix\n<\/p>\n

\n8. Research Methodology\n<\/p>\n

\nFor more information about this report visit https:\/\/www.researchandmarkets.com\/r\/rrmtlq<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nResearchAndMarkets.com
\n
Laura Wood, Senior Press Manager
\n
press@researchandmarkets.com<\/a><\/p>\n

For E.S.T Office Hours Call 1-917-300-0470
\n
For U.S.\/ CAN Toll Free Call 1-800-526-8630
\n
For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DUBLIN–(BUSINESS WIRE)–The “Global Chronic Pain Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products within the global Chronic Pain market. It covers emerging therapies for Chronic Pain in active clinical development stages including early and late stage clinical trials. The … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48074","6":"format-standard","7":"category-industry"},"yoast_head":"\nGlobal Chronic Pain Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN–(BUSINESS WIRE)–The “Global Chronic Pain Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products within the global Chronic Pain market. It covers emerging therapies for Chronic Pain in active clinical development stages including early and late stage clinical trials. The ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-07T17:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220907006099\/en\/1564348\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report – ResearchAndMarkets.com\",\"datePublished\":\"2022-09-07T17:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/\"},\"wordCount\":288,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006099\\\/en\\\/1564348\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/\",\"name\":\"Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006099\\\/en\\\/1564348\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-07T17:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006099\\\/en\\\/1564348\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006099\\\/en\\\/1564348\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report – ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN–(BUSINESS WIRE)–The “Global Chronic Pain Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products within the global Chronic Pain market. It covers emerging therapies for Chronic Pain in active clinical development stages including early and late stage clinical trials. The ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-07T17:01:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220907006099\/en\/1564348\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report – ResearchAndMarkets.com","datePublished":"2022-09-07T17:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/"},"wordCount":288,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220907006099\/en\/1564348\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/","name":"Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220907006099\/en\/1564348\/21\/logo.jpg","datePublished":"2022-09-07T17:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220907006099\/en\/1564348\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220907006099\/en\/1564348\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-chronic-pain-clinical-trial-pipeline-highlights-2022-report-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report – ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48074"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48074\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}